Process for preparing pharmaceutically active compounds and inte

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546115, 546223, C07D21122, C07D21158, C07D49804

Patent

active

061537551

ABSTRACT:
##STR1## A process is disclosed for the preparation of (1) by reduction of (2) directly using catalytic transfer hydrogenation to suppress formation of (4) or by conventional reduction via (4). Compound (1) is a key intermediate for inter alia paroxetine.

REFERENCES:
patent: 4007196 (1977-02-01), Christensen et al.
patent: 4585777 (1986-04-01), Lassen et al.
patent: 4593036 (1986-06-01), Lassen et al.
patent: 4861893 (1989-08-01), Borrett
patent: 4902801 (1990-02-01), Faruk et al.
patent: 5039803 (1991-08-01), Smith et al.
patent: 5258517 (1993-11-01), Zepp et al.
patent: 5328917 (1994-07-01), Jakonson et al.
patent: 5665736 (1997-09-01), Forguet et al.
patent: 5681962 (1997-10-01), Callander
Micovic et al., J. Chem. Soc., Perk Trans. 1, No. 16, pp. 2041-2050 (1996).
Carey, Organic Chemistry, McGraw-Hill Book Co., p. 566 (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for preparing pharmaceutically active compounds and inte does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for preparing pharmaceutically active compounds and inte, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing pharmaceutically active compounds and inte will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1727075

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.